The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors

MLA

Lambert, Sm, et al. The Crystal Structure of NS5A Domain 1 from Genotype 1a Reveals New Clues to the Mechanism of Action for Dimeric HCV Inhibitors. June 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1032..378e39924bbc6819d33988e2b1b2212f&authtype=sso&custid=ns315887.

APA

Lambert, S., Langley, D., Garnett, J., Angell, R., Hedgethorne, K., Meanwell, N., & Matthews, S. (2014). The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors.

Chicago

Lambert, Sm, Dr Langley, Ja Garnett, R Angell, K Hedgethorne, Na Meanwell, and Sj Matthews. 2014. “The Crystal Structure of NS5A Domain 1 from Genotype 1a Reveals New Clues to the Mechanism of Action for Dimeric HCV Inhibitors,” June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1032..378e39924bbc6819d33988e2b1b2212f&authtype=sso&custid=ns315887.